HeartPhone Cancer Survivors Trial 2019

NCT03953326 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Futility in recruitment

Conditions

Breast Cancer
Leukemia
Lymphoma

Interventions

BEHAVIORAL: HeartPhone app
DRUG: Acetylcholine
DRUG: Sodium Nitroprusside
DRUG: L-Arginine, N2-((4-Methylphenyl)Sulfonyl)-, Methyl Ester

Sponsor

Penn State University